欢迎来到 登录 未经易推广诚信审核

齐一生物科技(上海)有限公司

产品介绍

人游离脂肪酸(FFA)ELISA试剂盒

价 格:¥电议

型 号:

产品完善度:

生产地:其他访问量:20次

发布日期:2016/6/1 23:01:31

更新日期:2017/12/6 9:12:40

详细内容

 人游离脂肪酸(FFAELISA试剂盒科研之路。您我并肩同行!齐一生物具有完善的ELISA试剂盒开发平台,成熟的抗原、抗体研发系统,熟练掌握各种酶联技术,如双抗夹心法、(直接)竞争法、间接竞争法、阻断法、间接法、双抗原夹心法等方法,结合我公司的诊断试剂开发团队我们可以有效的将试剂盒开发为临床诊断级别,质量处于全国前茅。齐一生物针对中高端客户推出自主品牌QIYBO试剂盒为了保证客户用货质量,我公司采用纯进口原料现包被生产,质量稳定高. 齐一生物销售:0216034 8496181214 53965173021 04490欢迎您的咨询购买

【友情提示】:本产品仅供科研研究使用,不得用于人体临床直接检测。避免给您带来不必要的损失,请仔细阅读购买说明!

齐一生物现货供应人ELISA试剂盒,大鼠ELISA试剂盒,小鼠ELISA试剂盒等现货充足,购买任意ELISA试剂盒都享受免费代测服务,更多进口原装品牌试剂盒供应齐一生物销售:021-6034 8496;181214 53965;173021 04490

人游离脂肪酸(FFAELISA试剂盒酶法检测试验所需自备物品:

1. 酶标仪(450nm 波长滤光片)

2. 高精度移液器,EP 管及一次性吸头

3. 37℃恒温箱,双蒸水或去离子水

4. 吸水纸

试剂盒安全性提示:

1.工作人员实验中避免直接接触终止液和底物AB。一旦接触到这些液体,请尽快用水冲洗。

2.实验中不要吃喝、抽烟或使用化妆品。

3.不要用嘴吸取试剂盒里的任何成份。

人游离脂肪酸(FFAELISA试剂盒操作注意事项:

1.试剂盒应按标签说明书储存,使用前恢复到室温30分钟后方可使用。稀稀过后的标准品应丢弃,不可保存。

2.实验中不用的板条应立即放回包装袋中,密封保存,以免变质。

3.不用的其它试剂应包装好或盖好。不同批号的试剂不要混用.请在试剂盒保质前使用。

4.使用一次性的吸头以免交叉污染,吸取终止液和底物AB液时,避免使用带金属部分的加样器。

5.使用干净的塑料容器配置洗涤液。使用前充分混匀试剂盒里的各种成份及样品。

6.洗涤酶标板时应充分拍干,不要将吸水纸直接放入酶标反应孔中吸水。

7.底物A应挥发,避免长时间打开盖子。底物B对光敏感,避免长时间暴露于光下。避免用手接触,有毒。实验完成后应立即读取OD值。

8.加入试剂的顺序应一致,以保证所有反应板孔温育的时间一样。

9.按照说明书中标明的时间、加液的量及顺序进行温育操作。

人游离脂肪酸(FFAELISA试剂盒齐一生物客户寄标本时需注明以下情况:

1、标本编号;2、所测项目;3、是否做复孔;3、联系方式;4、实验后标本是否寄回。

客户必知:

客户应对所提供的材料及信息负责,如因客户提供的材料及信息不准确而引起的实验延误或经济损失由客户承担。

齐一生物供应ELISA试剂盒检测的目的是为实验提供准确可靠的定量分析实验依据。为了保证实验数据的可靠性,在实验过程中必须坚持全面质量控制和全过程质量控制。在收集标本前都必须有一个完整的计划。

样本保存条件:

1.2-8℃冰箱多放2

2.-20-50℃的冰箱可以放3-6个月

3.-50℃以下的冰箱,可以放一年

样本收集

1.血清样本用干燥管(红色)或者促凝管(黄色)收集

2.血浆用抗凝管,一般有EDTA抗凝(紫色)、枸橼酸钠抗凝(黑色或者蓝色)

3.动物组织匀浆(细胞):

              1g组织加入9ml PBS(浓度为0.1MpH7.4的)测分泌型指标

              1g组织加入1ml组织裂解液加入8ml PBS 测细胞内

粪便样本:1g样本+9ml PBS(浓度为0.01MpH7.4的)

没有PBS的话也可以用一下生理盐水,还是用PBS

样本离心转速及时间

1.试管采集的样本:3000转,离心五分钟取上清

2.离心管或者EP管采集的样本:5000--80003分钟取上清

3..样本保存--如果样品不立即使用,应将其分成小部分-70 ℃保存,避免反复冷冻。尽可能的不要使用溶血或高血脂血。如果血清中大量颗粒,检测前先离心或过滤。不要在37℃或更高的温度加热解冻。应在室温下解冻并确保样品均匀地充分解冻。

人游离脂肪酸(FFAELISA试剂盒齐一生物供应,以上资料供参考如有疑问需要详细资料请联系我们客服人员,齐一生物销售:0216034 8496181214 53965173021 04490

 

9242546Probe Holder Assembly, LX200, LCCNY

9242152Upgrade, CAS1820 vacuum DX/VX"The Upgrade, CAS 1820 vacuum DX/VX upgrades the X-tractorgene to use the improved vacuum system for the QIAxtractor. The upgrade is conducted as an on-site service, performed by a QIAGEN service specialist.

The upgrade allows for the usage of the QIAGEN DX and VX capture plates and the disposable silicon mats.

During the service, the new vacuum system is installed and the software is updated. Please note that due to the software upgrade the instrument will only run the QIAxtractor software applications. Customized run files from the previous version will have to be adapted beforehand for additional fees."CNY

5000-1404Plate Cartridge 110V, VTX2CNY

5000-1277Top Housing W LID, DML2CNY

5050-1029Mouse, PC System spareCNY

5025-1011Expand 4 Pipettor 240VCNY

9240747Belt, Reagent Pump 117 groove, APCNY

9240720Cable Carrier, Tubing, Dispense Head, APCNY

9240700Tubing, Waste, 1 1\4", APCNY

9243690DML Luminometer, Repair FeeDML Repair Fee covers Regional Repair Center service for non-service agreement covered DML 2000 and DML 3000 units. Includes labor, parts and shipping materials.CNY

9243652Comprehen Valid., QuantiPlex/QP Hyres"""The Comprehensive Validation Support plan specific to a laboratory's needs will incorporate all of the requirements for the internal validation guidelines from the FBI's Quality Assurance Standards (QAS).

 

The Comprehensive Validation Support service includes all travel and labor charges for up to 20 days by the QIAGEN Validation Team. Typically, one week will be required to extract, quantify, and amplify the validation study samples and may require multiple individuals. Usually, two weeks is required to analyze the data and one week to write the final report. The expected time period to complete the Comprehensive Validation is six weeks. The actual time may vary depending on resource availability, including laboratory time dedicated to validation activities.

 

Lab Work – The QIAGEN specialist(s) will travel to the laboratory to conduct the on-site validation lab work. The QIAGEN specialist team will perform and complete all extractions, quantifications, amplfications, and capillary electrophoresis. The laboratory is responsible for providing systems/protocols that may be needed (generally laboratory SOPs, ex. interpretation guidelines). Additionally, the laboratory staff may be required to provide additional data needed for interpretation (ex. quantification/amplification/CE results) during the data review phase of the validation. 

Once the final scope of the validation is determined, QIAGEN will provide a quote for all consumables required for the validation.  Non-QIAGEN chemistry and accessories are not included and should  be purchased to cover the validation experimental design including qPCR, STR, NIST standards, required samples types (blood, semen, buccal samples) and required substrates (swabs, materials, etc).   For planning purposes and to ensure a smooth process, the Customer is expected to have all materials on-hand and inventoried one (1) week prior to the validation start date.

 

Data Analysis – The Comprehensive Validation Support plan encompasses data collection (quants, amps, CE) during the on-site visit. The laboratory may be responsible for sharing (typically electronically via e-mail) any validation data requested after the on-site visit. A QIAGEN specialist will complete all of the data analysis produced from the validation study design. This includes qPCR (quant) and STR (amp) analysis and linkage to starting samples.

 

Validation data CD/flashdrive – QIAGEN will review the validation data and draft a validation summary document, ensuring compliance with the FBI's QAS requirements/standards. QIAGEN will send validation data in an electronic format (email/CD/flashdrive) to the laboratory. The laboratory is responsible for final compilation, any format change preferences, review and signoff of the validation report. The documentation provided by QIAGEN will aide in demonstrating compliance with all accreditation guidelines during laboratory audits. Should a hard copy of the validation study be preferred, the laboratory is required to specify prior to the onset of the validation.

 

Post-validation QIAGEN-to-Laboratory Transfer – Following completion of the validation and generation of the draft validation summary document, a designated member of the QIAGEN validation team will review the validation with the Lab Manager and the Technical Leader. Following sign off on the validation report, training of the laboratory DNA staff will occur. Refer to the Post-validation Competency Training for additional information. """CNY

6000-3101Rapid Capture SystemCNY

19134QIAGEN Proteinase KCNY

614033careHPV Test, SFDA (24-test)CNY

274203flocktype IBDV Ab (5)CNY

270803cattletype MAP Ab (5)CNY

280303cador BVDV RT-PCR Kit (24)CNY

282303virotype PRRSV RT-PCR Kit (24)CNY

282305virotype PRRSV RT-PCR Kit (96)CNY

280443virotype BTV pan/8 RT-PCR Kit (24)CNY

939012Buffer N2 (2 x 10 ml)CNY

871105EGFR PCR Kit (100)CNY

800382Restriction MapCNY

871005KRAS PCR Kit (100)CNY

9020586Power Supply, 24V 60W, DML 3000CNY

9013314Shaker adapter, 192-tube, 5 mlCNY

9013211Cabling kit, data, BR8000CNY

9011747Worktable left, BR8000 v1.01CNY

132568NeXtal Stock Methoxy-PEG 5000 (50)30% w/v Methoxypolyethylene glycol 5000 - 50mL (4 x 12,5 ml tube)CNY

 

800311Custom PrimerCNY


QY-x2044Tsu-pr1 非雄激素依赖型前列腺癌 1640+10%胎牛血清
QY-x2045HOS 骨肉瘤 MEM+非必需氨基酸+10%胎牛血清
QY-x2046MG-63 成骨肉瘤 MEM+非必需氨基酸+10%胎牛血清
QY-x2047Saos-2 骨肉瘤 1640+10%胎牛血清
QY-x2048U-2OS 骨肉瘤 1640+10%胎牛血清
QY-x2049OS-732 骨肉瘤 1640+10%胎牛血清 瘤株
QY-x2050A-204 横纹肌肉瘤
QY-x2051HT1080 纤维肉瘤 1640+10%胎牛血清
QY-x2052A375 皮肤黑色素瘤 DMEM+10%胎牛血清
QY-x2053细胞中心实验室细胞库部分细胞系目录(鼠类肿瘤细胞)
QY-x20541.小鼠类
QY-x2055细胞名称 组织类型 培养条件
QY-x2056Lewis 肺癌 瘤株
QY-x2057LA795 肺腺癌 瘤株
QY-x2058EAC 艾氏腹水瘤 瘤株
QY-x2059S180 腹水瘤 瘤株
QY-x2060H22 肝癌 瘤株
QY-x2061H22 肝癌 1640+10%胎牛血清 体外培养株
QY-x2062MPC-83 胰腺腺泡细胞癌 1640+10%胎牛血清 体外培养株
QY-x2063MPC-83 胰腺腺泡细胞癌 瘤株
QY-x2064RIN-m5F β胰岛素瘤 1640+10%胎牛血清 体外培养株
QY-x2065MA891 乳腺癌 瘤株
QY-x2066TA2 自发高乳腺癌 瘤株
QY-x2067U14 宫颈癌 瘤株
QY-x2068YAC-1 淋巴瘤 1640+10%胎牛血清 体外培养株
QY-x2069Nb2-11 淋巴瘤 体外培养株
QY-x2070C26 结肠癌 瘤株
QY-x2071G422 神经胶质瘤 瘤株
QY-x2072B16 黑色素瘤 1640+10%胎牛血清 体外培养株
QY-x2073B16 黑色素瘤 瘤株
 

提交询价

关闭